Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMA | ALKS | KYMR | ||
| Company | Adma Biologics | Alkermes Plc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.61 | 29.53 | 66.31 | ||
| High | 20.22 | 29.66 | 68.78 | ||
| Low | 19.56 | 28.96 | 65.24 | ||
| Latest | 20.11 | 29.30 | 66.23 | ||
| Change | +0.39 | -0.23 | +0.24 | ||
| % Change | +1.98% | -0.78% | +0.36% | ||
| Volume | 2,726,800 | 1,376,000 | 741,600 | ||
| 20-Day Average Volume | 3,707,325 | 2,526,875 | 715,685 | ||
| Previous Close | 19.72 | 29.53 | 65.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.10 | 29.99 | 64.55 | ||
| 20-Day Raw Stochastic | 98.30% | 25.99% | 78.67% | ||
| 20-Day Relative Strength | 71.52 | 47.42 | 59.95 | ||
| Weighted Alpha | +10.88 | -6.65 | +30.58 | ||
| Today's Opinion | 24% Buy | 24% Sell | 100% Buy | ||
| Previous Opinion | 24% Buy | 8% Sell | 96% Buy | ||
| Last Month's Opinion | 100% Sell | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.07% since 11/26/25 | -1.41% since 11/26/25 | -2.40% since 11/26/25 | ||
| Low | 18.73 on 12/01/25 | 28.52 on 12/02/25 | 63.69 on 12/02/25 | ||
| High | 20.22 on 12/04/25 | 30.23 on 11/28/25 | 68.78 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +37.46% since 11/04/25 | -3.59% since 11/04/25 | +10.55% since 11/04/25 | ||
| Low | 13.76 on 11/07/25 | 27.49 on 11/12/25 | 56.75 on 11/07/25 | ||
| High | 20.22 on 12/04/25 | 36.32 on 11/05/25 | 68.80 on 11/24/25 | ||
| 3-Month | |||||
| %Chg | +18.96% since 09/04/25 | +1.31% since 09/04/25 | +56.94% since 09/04/25 | ||
| Low | 13.76 on 11/07/25 | 25.17 on 09/08/25 | 42.22 on 09/08/25 | ||
| High | 20.22 on 12/04/25 | 36.32 on 11/05/25 | 68.80 on 11/24/25 | ||
| 6-Month | |||||
| %Chg | -1.08% since 06/04/25 | -7.10% since 06/04/25 | +49.64% since 06/04/25 | ||
| Low | 13.76 on 11/07/25 | 25.17 on 09/08/25 | 36.65 on 08/11/25 | ||
| High | 22.37 on 06/11/25 | 36.32 on 11/05/25 | 68.80 on 11/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,786,140 | 4,837,957 | 4,765,182 | ||
| Shares Outstanding, K | 237,998 | 165,118 | 71,949 | ||
| Annual Sales | 426,450,000 | 1,557,630,000 | 47,070,000 | ||
| Annual Net Income | 197,670,000 | 367,070,000 | -223,860,000 | ||
| Last Quarter Sales | 134,220,000 | 394,190,000 | 2,760,000 | ||
| Last Quarter Net Income | 36,430,000 | 82,760,000 | -82,180,000 | ||
| 60-Month Beta | 0.43 | 0.49 | 2.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 11/05/25 | 0.49 on 10/28/25 | -0.90 on 11/04/25 | ||
| Latest Earnings Date | 11/05/25 | 10/28/25 | 11/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 33.42 | 14.34 | 0.00 | ||